Market Closed -
Other stock markets
|
Pre-market 05:48:21 pm | |||
127.5 USD | -0.58% | 127.3 | -0.17% |
02/05 | Merck: encouraging results in gastric cancer | CF |
01/05 | Merck Says Keytruda Meets Primary Endpoint in Late-Stage Gastric Cancer Trial | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.97% | 323B | |
+26.08% | 662B | |
+21.17% | 546B | |
-4.77% | 359B | |
+5.69% | 289B | |
+13.68% | 234B | |
+4.62% | 198B | |
-10.55% | 194B | |
+8.08% | 167B | |
-3.40% | 157B |
- Stock Market
- Equities
- MRK Stock
- News Merck & Co., Inc.
- Gilead, Merck & Co. to Evaluate Lung Cancer Combo Therapy in Two Clinical Studies